| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Dermata Therapeutics, Inc.
13D/A
Amendment 10
DRMA · 249845504
|
17.3% |
2/23/2026
Event 2/19/2026
|
|||
|
Dermata Therapeutics, Inc.
13D/A
Amendment 9
DRMA · 249845504
|
19.6% |
2/2/2026
Event 1/29/2026
|
|||
|
Dermata Therapeutics, Inc.
13D/A
Amendment 8
DRMA · 249845504
|
24.7% |
1/8/2026
Event 12/23/2025
|
|||
| Proehl Gerald T | 24.7% | ||||
| Proehl Investment Ventures LLC | 2.8% | ||||
|
Dermata Therapeutics, Inc.
13D/A
Amendment 7
DRMA · 249845405
|
13.3% |
4/7/2025
Event 3/27/2025
|
|||
| Proehl Gerald T | 13.3% | ||||
| Proehl Investment Ventures LLC | 13.3% | ||||
|
Dermata Therapeutics, Inc.
13D/A
Amendment 6
DRMA · 249845108
|
7.8% |
4/3/2025
Event 3/27/2025
|
|||
| Proehl Gerald T | 7.8% | ||||
| Proehl Investment Ventures LLC | 7.8% | ||||
|
Dermata Therapeutics, Inc.
13D/A
Amendment 5
DRMA · 249845108
|
15.0% |
2/13/2025
Event 1/24/2025
|
|||
| Proehl Gerald T | 15.0% | ||||
| Proehl Investment Ventures LLC | 14.9% | ||||
|
Dermata Therapeutics, Inc.
13D/A
Amendment 4
DRMA · 249845108
|
16.0% |
1/23/2025
Event 1/21/2025
|
|||
| Proehl Gerald T | 16.0% | ||||
| Proehl Investment Ventures LLC | 15.9% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.